US 8816088
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
granted A61KA61K31/444A61K31/4709
Quick answer
US patent 8816088 (Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity) held by Theravance Respiratory Company, LLC expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Respiratory Company, LLC
- Grant date
- Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/444, A61K31/4709, A61K31/56, A61K45/06